We are live on ! Find out more
MRVI icon

Maravai LifeSciences
MRVI

150 hedge funds and large institutions have $313M invested in Maravai LifeSciences in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 44 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,292% more call options, than puts

Call options by funds: $1.85M | Put options by funds: $133K

30% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 44

7% more capital invested

Capital invested by funds: $292M → $313M (+$20.4M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

2.08% less ownership

Funds ownership: 92.15% → 90.07% (-2.1%)

18% less funds holding

Funds holding: 184 → 150 (-34)

62% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 52

Holders
150
Holders Change
-34
Holders Change %
-18.48%
% of All Funds
1.97%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
20
Increased
57
Reduced
44
Closed
52
Calls
$1.85M
Puts
$133K
Net Calls
+$1.72M
Net Calls Change
+$1.38M

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$5.63M
2
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$5.56M
3
PD
Point72 (DIFC)
United Arab Emirates
+$4.55M
4
TC
Tejara Capital
United Kingdom
+$2.94M
5
FPA
First Pacific Advisors
California
+$1.56M

Top Sellers

Rank Fund Capital Flow
1
MFS
Mirabella Financial Services
United Kingdom
-$7.84M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$4.79M
3
Millennium Management
Millennium Management
New York
-$2.37M
4
Ameriprise
Ameriprise
Minnesota
-$1.77M
5
PHP
Parkman Healthcare Partners
Connecticut
-$1.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$2.48M +$318K +151,205 +17%
Northern Trust
27
Northern Trust
Illinois
$2.4M -$198K -94,153 -9%
I
28
Immersion
Florida
$2.39M +$1.26M +599,164 +153%
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$2.27M -$658K -313,141 -25%
Charles Schwab
30
Charles Schwab
California
$2.24M -$41.8K -19,870 -2%
MAM
31
Monaco Asset Management
Monaco
$2.12M +$94.8K +45,100 +5%
PCM
32
PenderFund Capital Management
British Columbia, Canada
$2.1M +$92.3K +43,900 +5%
FPA
33
First Pacific Advisors
California
$1.79M +$1.56M +741,332 New
SG Americas Securities
34
SG Americas Securities
New York
$1.75M +$64.8K +30,835 +4%
EP
35
Eversept Partners
New York
$1.54M -$634K -301,781 -32%
Citadel Advisors
36
Citadel Advisors
Florida
$1.47M -$967K -460,059 -43%
DIM
37
Delta Investment Management
California
$1.23M +$139K +66,252 +15%
HCM
38
Harspring Capital Management
New York
$1.21M +$1.05M +500,000 New
Hudson Bay Capital Management
39
Hudson Bay Capital Management
Connecticut
$1.03M – – –
CIBC Private Wealth Group
40
CIBC Private Wealth Group
Georgia
$992K -$261 -124 -0%
JP Morgan Chase
41
JP Morgan Chase
New York
$860K -$675K -321,305 -47%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$837K +$111K +52,982 +18%
Marshall Wace
43
Marshall Wace
United Kingdom
$776K -$151K -71,902 -18%
BCI
44
Brinker Capital Investments
Pennsylvania
$776K +$173K +82,522 +34%
Invesco
45
Invesco
Georgia
$680K +$85.1K +40,495 +17%
QOP
46
Quinn Opportunity Partners
Virginia
$639K – – –
Millennium Management
47
Millennium Management
New York
$598K -$2.37M -1,128,634 -82%
Citigroup
48
Citigroup
New York
$593K +$327K +155,701 +172%
VIM
49
VELA Investment Management
Ohio
$586K +$182K +86,628 +55%
N
50
Nuveen
North Carolina
$581K -$127K -60,390 -20%
1
2
3 4 5

MRVI Hedge Fund Activity: Q2 2025 in Review

150 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q2 2025, worth a combined $313M — up 7% from $292M a quarter earlier.

Sellers outnumbered buyers: 52 funds closed out of MRVI and 20 opened new positions — a net loss of 32 holders — while 44 trimmed existing stakes and 57 added.

The largest buyer was UBS Group, adding an estimated $5.63M. The largest seller was Mirabella Financial Services, cutting an estimated $7.84M.

  • 150 institutional investors held Maravai LifeSciences (MRVI) as of Q2 2025, down from 184 in Q1 2025.
  • Funds reported $313M of Maravai LifeSciences stock for Q2 2025, up 7% quarter-over-quarter.
  • 20 funds opened new Maravai LifeSciences positions in Q2 2025 and 52 closed out, a net change of -32 holders.
  • The largest Maravai LifeSciences buyer in Q2 2025 was UBS Group, an estimated $5.63M added.
  • The largest Maravai LifeSciences seller in Q2 2025 was Mirabella Financial Services, an estimated $7.84M sold.

Based on aggregated 13F filings for Q2 2025.